Publikationen von Schoemans, Helene

Perovic, Vladimir , Sabol, Ivan , Grce, Magdalena , Inngjerdingen, Marit, Pulanic, Drazen, Peric, Zinaida, Peczynski, Christophe , Polge, Emmanuelle , Koenecke, Christian , Dickinson, Anne, Greinix, Hildegard, Basak, Grzegorz, Penack, Olaf , Scherwath, Angela, Barata, Anna, Olivieri, Attilio, Lawitschka, Anita, Mensah-Glanowska, Patrycja, Andrikovics, Hajnalka, Schoemans, Helene und Wolff, Daniel (2022) Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network. Bone Marrow Transplantation 57, S. 1458-1460.

Herrmann, Anne , Parisek, Mira, Loss, Julika, Holler, Ernst, Barata, Anna, Weber, Daniela, Edinger, Matthias, Wolff, Daniel und Schoemans, Helene (2021) “This Graft-vs.-Host Disease Determines My Life. That's It.”—A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany. Frontiers in Public Health 2021 (9), S. 687675. (Eingereicht)

Pidala, Joseph, Kitko, Carrie, Lee, Stephanie J., Carpenter, Paul, Cuvelier, Geoffrey D.E., Holtan, Shernan , Flowers, Mary E., Cutler, Corey, Jagasia, Madan, Gooley, Ted, Palmer, Joycelynne, Randolph, Tim, Levine, John E., Ayuk, Francis, Dignan, Fiona, Schoemans, Helene, Tkaczyk, Eric , Farhadfar, Nosha, Lawitschka, Anita, Schultz, Kirk R., Martin, Paul J., Sarantopoulos, Stefanie, Inamoto, Yoshihiro, Socie, Gerard, Wolff, Daniel, Blazar, Bruce, Greinix, Hildegard, Paczesny, Sophie, Pavletic, Steven und Hill, Geoffrey (2021) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report. Transplantation and Cellular Therapy 27 (8), S. 632-641. Volltext nicht vorhanden.

Wolff, Daniel, Bardak, Jelena, Edinger, Matthias, Klinger-Schindler, Ursula, Holler, Ernst , Lawitschka, Anita , Schoemans, Helene, Herr, Wolfgang, Kröger, Nikolaus und Ayuk Ayuketang, Francis (2020) Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation–An Analysis of 2 German Transplantation Centers. Frontiers in Public Health 8 (572470), S. 1-8.